GSK plc Share Price & Technical Analysis
GSK · $51.38 (-0.29%)
Healthcare / Drug Manufacturers - General
$51.38
-0.29%
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, infla…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-1% return in May, 1% avg return in past 3 year May month.
6% return in 2026, 15% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 5% | 13% | -6% | -6% | -1% | – | – | – | – | – | – | – | 6% |
| 25 | 4% | 8% | 1% | 3% | 4% | -7% | -3% | 5% | 10% | 6% | 2% | 2% | 35% |
| 24 | 7% | 5% | 2% | -3% | 5% | -7% | 1% | 13% | -6% | -9% | -9% | -1% | -3% |
| 23 | 1% | -3% | 4% | 1% | -7% | 6% | 0% | 0% | 3% | -1% | 5% | 3% | 13% |
| 22 | 2% | -7% | 4% | 4% | -3% | 0% | -2% | -23% | -8% | 11% | 3% | 1% | -18% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$102.42B
P/E ratio
13.15
52W high
$61.70
52W low
$35.45
Volume
28,19,836
Beta
0.30
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is GSK plc share price today?
- GSK plc (GSK) last traded around $51.38 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GSK have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GSK. Download the app for real-time alerts.
- How can I analyze GSK plc stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.